Systemic Sclerosis Clinical Trial
Official title:
Effects of an Individualized, Home-based Exercise Program for the Patient With Systemic Sclerosis, on Exercise Capacity, Hand Mobility and Quality of Life: a Randomized, Controlled Study.
Systemic sclerosis (SSc) is an uncommon chronic rheumatic disease with an unknown cause and
unpredictable course. The inability, in addition to easy fatigability, starts a vicious
circle that leads to a fast deterioration of physical conditions that cause a reduction of
aerobic exercise capacity and, consequently, of health-related quality of life (HRQoL).
Aerobic exercise has already been shown to be safe and effective in improving exercise
capacity and HRQoL of patients with chronic cardiovascular and pulmonary diseases. However,
few studies have evaluated the role of specific exercise programs on the muscular impairment
in SSc. Nevertheless, the results obtained in preliminary reports are promising, and, for
these reasons, the management of muscular impairment in SSc could include an appropriate
rehabilitation program besides pharmaceutical and surgical treatments.
The primary aim of this study will be to evaluate the effect of an individualized exercise
program performed at home on aerobic capacity evaluated by 6 minutes walking test.
Secondary aims will be to evaluate: 1- VO2max, measured by cardiopulmonary test; 2- the
effect of the same program on the muscular strength of upper and lower limbs; 3- the efficacy
of a self-administered stretching program for finger joint motion. Secondary aims will be
also 1-to ascertain whether a comprehensive exercise program may affect, besides physical
function, HRQoL; 2- and to evaluate the adherence during two periods of three months, one
whit and one without supervision and reinforcement by a phone call.
All the patients with a diagnosis of SSc, according to the criteria of American College of
Rheumatology (ACR), who attended the Rheumatologic outpatient clinic of our institution will
be evaluated in order to participate in the rehabilitation program. The pneumological
examination and two days of screening and testing will take place at the outpatient's clinic
of Respiratory Medicine and Sport of our institution.
This will be a randomized, controlled, six months parallel group study. The flow chart of the
study is reported in table 1. Participants initially will undergo 2 days of screening and
testing. During the first visit patients will sign an informed consent, will undergo clinical
assessment, pulmonary function testing, measurement of anthropometric data and body
composition by bioimpedentiometry. They will perform a graded exercise test on a
cycloergometer and will complete questionnaires to assess HRQoL (short form-36, SF-36) and
functional abilities (health assessment questionnaire disability index, HAQ-DI). During the
second visit, the participants will carry out the hand mobility in scleroderma test (HAMIS),
six minutes walking test (6MWT), will undergo measurements of quadriceps and biceps strength,
and handgrip test. After completion of testing and screening, patients who will meet the
selection criteria will be randomly assigned to one of two groups 1) home-care rehabilitation
group (HCRG); 2) control group (CG). The first group will begin a six months program of
exercise training. The patients of the second group will be given generic recommendations to
increase physical activity.
The patients in the first group, during a session in our outpatient clinic, will be
instructed by a physiotherapist how to perform the physical exercise program at home. In
particular, they will learn how to use the stationary bike and how to perform the exercises
for upper limbs. Furthermore, the patient of the first group will be instructed how to fill
in a card in which they will record the exercises performed daily. Throughout the first three
months of the training period, the patients received a phone call from a physiotherapist once
monthly, during which the adherence to exercise program will be reinforced. Particularly, it
will be asked about the adherence to and the acceptance of exercise program, and the presence
of side effects. Also, the control group will receive a phone call with the same schedule,
but only in order to evaluate health status and to give a general recommendation about the
positive effect of the aerobic exercise. From the third to the sixth month, both groups will
not receive a monthly call, in order to evaluate the adherence to the program in the absence
of supervision.
After 3 and 6 months, the subjects will undergo a complete 2 days of testing, using the same
schedule described for a baseline.
The exercise program consists of aerobic exercise on a stationary bike, muscular endurance
training of the upper limb and stretching exercises for finger joint motion. The exercise on
the stationary bike and muscular endurance training will be performed on alternate days,
three times a week.
A stationary cycle (Energetics ct220p, Neomark Sarl, Luxembourg) will be given to each
patient for lower limb training. Each session will consist of three phases. In the first one,
the patient will pedal for 5 minutes without inserting the brake. In the second phase, the
patient will be instructed to set the brake at a load equal to 60% of the watts achieved at
the peak of the maximal ergocycle exercise test. This phase consists in two periods of
fifteen minutes divided by recovery interval of three minutes. It will be followed by five
minutes of cool-down without load. The frequency of pedalling will be about 60 rotation/min
during the second phase and less than 50 during the other phases.
For upper limbs training the patients will perform ten repetitions for three times that
consists in lifting and lowering repeatedly a weight from the waist to the shoulders,
alternating periods of exercise and three minutes of rest. The load will be calculated as the
60% of predicted 1-RM. Warm up and stretching of upper limbs, shoulders and neck will be
performed before and after each exercise session respectively.
For the first two weeks, for both types of exercises of the program, the load will be reduced
by 20%.
For finger stretching to the patients will be given written and illustrated instructions on
self-administered exercises, and will be directed to perform it every day, both in the
morning and in the evening.
During the rehabilitation period, the patients will report each day on a diary for each type
of exercise whether the tasks were complete, partially or not executed which corresponds a
score of 1, 0.5, 0 respectively.
The attendance rate at the training session will be calculated by the ratio between the
amount of the score obtained from the diary and the scheduled sessions multiplied for 100.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03274076 -
Evaluation of Tofacitinib in Early Diffuse Cutaneous Systemic Sclerosis (dcSSc)
|
Phase 1/Phase 2 | |
Completed |
NCT04300426 -
Safety and Efficacy of Anaerobic Cultivated Human Intestinal Microbiome Transplantation in Systemic Sclerosis (ReSScue)
|
Phase 2 | |
Recruiting |
NCT06058091 -
RY_SW01 Cell Injection Therapy in Systemic Sclerosis
|
Phase 1/Phase 2 | |
Recruiting |
NCT04356755 -
Subcutaneous Injections of ASC to Heal Digital Ulcers in Patients With Scleroderma.
|
Phase 2 | |
Suspended |
NCT06210945 -
Study to Evaluate the Safety, Tolerability, and Activity of CM-101 in Patients With Systemic Sclerosis
|
Phase 2 | |
Not yet recruiting |
NCT05947682 -
Manufacturing of Allogeneic Adipose Tissue-derived Mesenchymal Stromal Cells for Treatment of Severe Systemic Sclerosis
|
N/A | |
Not yet recruiting |
NCT05177380 -
Efficacy of a Personalized Rehabilitation Program of Facial Involvement in Systemic Sclerosis
|
N/A | |
Not yet recruiting |
NCT04303208 -
Sirtuin 3 and Sirtuin 7 in Systemic Sclerosis
|
N/A | |
Recruiting |
NCT02551042 -
CSL Behring Sclero XIII
|
Phase 2 | |
Terminated |
NCT02246348 -
Evaluating Lung Doppler Signals in Patients With Systemic Sclerosis (SSc)
|
N/A | |
Terminated |
NCT02243111 -
Detecting Pulmonary Arterial Hypertension (PAH) in Patients With Systemic Sclerosis (SSc) by Ultrasound
|
N/A | |
Completed |
NCT01933334 -
Safety and Tolerability of Pirfenidone in Patients With Systemic SclerosisâRelated Interstitial Lung Disease (SSc-ILD) (LOTUSS)
|
Phase 2 | |
Completed |
NCT01468792 -
Hemodynamic Changes in Connective Tissue Disease
|
N/A | |
Terminated |
NCT00848107 -
Open-Label Study of Oral Treprostinil in Digital Ulcers
|
Phase 2 | |
Completed |
NCT00984932 -
Effect of Rosuvastatin on Systemic Sclerosis-related Pulmonary Hypertension
|
Phase 3 | |
Completed |
NCT00074568 -
Scleroderma Registry
|
||
Not yet recruiting |
NCT06412614 -
Evaluation of Patients With Systemic Sclerosis Without Specific or Associated Autoantibodies
|
||
Terminated |
NCT00622687 -
Effect of Different Iloprost Doses on Symptoms in Systemic Sclerosis
|
Phase 2 | |
Recruiting |
NCT04464434 -
Upfront Autologous HSCT Versus Immunosuppression in Early Diffuse Cutaneous Systemic Sclerosis
|
Phase 4 | |
Recruiting |
NCT04246528 -
SPIN Self-Management Feasibility Trial With Progression to Full-scale Trial (SPIN-SELF)
|
N/A |